Search results

ANSTO has played a formative role and continues to make important contributions using nuclear and isotopic techniques to understand past climates and patterns of change, maintain water resource sustainability and provide insights into the impact of contaminate in the environment.

During the scheduled shutdown of the OPAL multi-purpose reactor, an ANSTO engineering and project team has installed a new safety shutdown instrumentation and control system (I&C).

A team of ANSTO health researchers, staff at the Centre for Accelerator Science and Dr Melanie Ferlazzo, a postdoc from the French National Institute of Health and Medical Research (INSERM), and scientists from the French Space Agency (CNES), are collaborating on investigations to determine the impact of secondary particles on human cells using the new microprobe beamline at ANSTO’s Centre for Accelerator Science.

Think Science! 2023 Summary and Results

ANSTO’s nuclear medicine processing and distribution facility assembles, loads, tests and distributes a range of nuclear medicine products, including Mo-99. The Mo-99 is dispensed into an ANSTO radiopharmaceutical Gentech® Generator where it decays to Tc-99m.

ANSTO has safely managed its radioactive waste for over 60 years. Waste is managed in accordance with national and international standards.

Inspiring young women to be part of next generation of scientists.

The Public Interest Disclosure Act 2013 aims to promote integrity and accountability in the Australian Public Sector by encouraging the disclosure of information about actual or suspected wrongdoing, protecting people who make disclosures and ensuring that disclosures are properly investigated and dealt with.

In collaboration with the French National Institute of Health and Medical Research (INSERM) and the French International Space Agency (CNES), ANSTO scientists are undertaking research on the radiobiological effects of secondary particles that are created when radiation interacts with the shielding on the International Space Station.

ANSTO is a highly regulated organisation. Our governance system and processes provide critical guidance to effectively manage ANSTO’s activities. This section outlines the processes and systems that are in place to provide assurance to Government, our stakeholders and the community that we are working within our regulated and mandated requirements.

Hudson Institute of Medical Research and Monash University researchers used synchrotron X-rays produce powerful visualisation of video of changes to blood flow to brain during ventilation in large preterm clinical models.

The SAAFE Program supports early career researchers at PhD and Postdoctoral level to expand research and innovation activities within Human Health, the Environment and the Nuclear Fuel Cycle, to initiate sustainable research networks and linkages to support Australia, New Zealand and France research and innovation.

Australian Nuclear Science and Technology Organisation (ANSTO) is committed to protecting your personal information in accordance with the Privacy Act 1988 (Cth) (Privacy Act) and the Australian Privacy Principles.

ANSTO has been tracking and publishing data on fine particle pollution from key sites around Australia, and internationally, for more than 20 years.  

The ANSTO Science Series is a live and virtual meet-up that focuses on the key capacities of ANSTO’s people, partners and facilities and how they are meeting global challenges in sustainable industries, medicine, advanced manufacturing and in accelerating small business.